Abstract |
Antibiotics blocking bacterial cell wall assembly ( beta-lactams and glycopeptides) are facing a challenge from the progressive spread of resistant pathogens. Lantibiotics are promising candidates to alleviate this problem. Microbisporicin, the most potent antibacterial among known comparable lantibiotics, was discovered during a screening applied to uncommon actinomycetes. It is produced by Microbispora sp. as two similarly active and structurally related polypeptides (A1, 2246-Da and A2, 2230-Da) of 24 amino acids linked by 5 intramolecular thioether bridges. Microbisporicin contains two posttranslational modifications that have never been reported previously in lantibiotics: 5-chloro-trypthopan and mono- (in A2) or bis-hydroxylated (in A1) proline. Consistent with screening criteria, microbisporicin selectively blocks peptidoglycan biosynthesis, causing cytoplasmic UDP-linked precursor accumulation. Considering its spectrum of activity and its efficacy in vivo, microbisporicin represents a promising antibiotic to treat emerging infections.
|
Authors | Franca Castiglione, Ameriga Lazzarini, Lucia Carrano, Emiliana Corti, Ismaela Ciciliato, Luciano Gastaldo, Paolo Candiani, Daniele Losi, Flavia Marinelli, Enrico Selva, Francesco Parenti |
Journal | Chemistry & biology
(Chem Biol)
Vol. 15
Issue 1
Pg. 22-31
(Jan 2008)
ISSN: 1074-5521 [Print] United States |
PMID | 18215770
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Bacterial Agents
- Bacteriocins
- Peptides
- Peptidoglycan
- microbisporicin
- Tryptophan
- Proline
|
Topics |
- Actinomycetales
(chemistry, drug effects, metabolism)
- Amino Acid Sequence
- Anti-Bacterial Agents
(chemistry, pharmacology)
- Bacteriocins
(chemistry, pharmacology)
- Drug Resistance, Multiple, Bacterial
(drug effects, physiology)
- Molecular Sequence Data
- Peptides
(chemistry, pharmacology)
- Peptidoglycan
(biosynthesis)
- Proline
(analogs & derivatives, pharmacology)
- Tryptophan
(analogs & derivatives, pharmacology)
|